Article
TNF-α Pretreatment Improves the Survival and Function of Transplanted Human Neural Progenitor Cells Following Hypoxic-Ischemic Brain Injury.
Cells - 11 May 2020
Kim Miri, Jung Kwangsoo, Ko Younhee, Kim Il-Sun, Hwang Kyujin, Jang Jae-Hyung, Shin Jeong Eun, Park Kook In
Abstract excerpt
Neural progenitor cells (NPCs) therapy offers great promise in hypoxic-ischemic (HI) brain injury. However, the poor survival of implanted NPCs in the HI host environment limits their therapeutic effects. Tumor necrosis factor-alpha (TNF-α) is a pleiotropic cytokine that is induced in response to a variety of pathological processes including inflammation and immunity. On the other hand, TNF-α has protective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
